Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura Icardi is active.

Publication


Featured researches published by Laura Icardi.


Nature Methods | 2013

The need for transparency and good practices in the qPCR literature

Stephen A. Bustin; Vladimir Benes; Jeremy A. Garson; Jan Hellemans; Jim F. Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W. Pfaffl; Gregory L. Shipley; Carl T. Wittwer; Peter Schjerling; Philip J. R. Day; Mónica Abreu; Begoña Aguado; Jean-François Beaulieu; Anneleen Beckers; Sara Bogaert; John A. Browne; Fernando Carrasco-Ramiro; Liesbeth Ceelen; Kate L. Ciborowski; Pieter Cornillie; Stephanie Coulon; Ann Cuypers; Sara De Brouwer; Leentje De Ceuninck; Jurgen De Craene; Hélène De Naeyer; Ward De Spiegelaere

Two surveys of over 1,700 publications whose authors use quantitative real-time PCR (qPCR) reveal a lack of transparent and comprehensive reporting of essential technical information. Reporting standards are significantly improved in publications that cite the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines, although such publications are still vastly outnumbered by those that do not.


Proceedings of the National Academy of Sciences of the United States of America | 2012

The Sin3a repressor complex is a master regulator of STAT transcriptional activity

Laura Icardi; Raffaele Mori; Viola Gesellchen; Sven Eyckerman; Lode De Cauwer; Judith Verhelst; Koen Vercauteren; Xavier Saelens; Philip Meuleman; Geert Leroux-Roels; Karolien De Bosscher; Michael Boutros; Jan Tavernier

Tyrosine phosphorylation is a hallmark for activation of STAT proteins, but their transcriptional activity also depends on other secondary modifications. Type I IFNs can activate both the ISGF3 (STAT1:STAT2:IRF9) complex and STAT3, but with cell-specific, selective triggering of only the ISGF3 transcriptional program. Following a genome-wide RNAi screen, we identified the SIN3 transcription regulator homolog A (Sin3a) as an important mediator of this STAT3-targeted transcriptional repression. Sin3a directly interacts with STAT3 and promotes its deacetylation. SIN3A silencing results in a prolonged nuclear retention of activated STAT3 and enhances its recruitment to the SOCS3 promoter, concomitant with histone hyperacetylation and enhanced STAT3-dependent transcription. Conversely, Sin3a is required for ISGF3-dependent gene transcription and for an efficient IFN-mediated antiviral protection against influenza A and hepatitis C viruses. The Sin3a complex therefore acts as a context-dependent ISGF3/STAT3 transcriptional switch.


Cytokine & Growth Factor Reviews | 2012

The HAT/HDAC interplay: multilevel control of STAT signaling

Laura Icardi; Karolien De Bosscher; Jan Tavernier

Besides the transcription-promoting role of histone acetyltransferases (HATs) and the transcription-delimiting function of histone deacetylases (HDACs) through histone acetylation and deacetylation respectively, HATs and HDACs also regulate the activity of several non-histone proteins. This includes signal transducers and activators of transcription (STATs), key proteins in cytokine signaling. Unlike Tyr phosphorylation/dephosphorylation, which mainly acts as an on/off switch of STAT activity, the control exerted by HATs and HDACs appears multifaceted and far more complex than initially imagined. Our review focuses on the latest trends and novel hypotheses to explain differential context-dependent STAT regulation by complex posttranslational modification patterns. We chart the knowledge on how STATs interact with HATs and HDACs, and additionally bring a transcriptional regulatory and gene-set specific role for HDACs in the picture. Indeed, a growing amount of evidence demonstrates, paradoxically, that not only HAT but also HDAC activity can be required for STAT-dependent transcription, in a STAT subtype- and cell type-dependent manner. Referring to recent reports, we review and discuss the various molecular mechanisms that have recently been proposed to account for this peculiar regulation, in an attempt to shed more light on the difficult yet important question on how STAT specificity is being generated.


The FASEB Journal | 2012

Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2

Laura Icardi; Sam Lievens; Raffaele Mori; Julie Piessevaux; Lode De Cauwer; Karolien De Bosscher; Jan Tavernier

The antiviral and antiproliferative responses mediated by type I interferons (IFNs) depend on JAK/STAT signaling and ISGF3 (STAT1:STAT2: IRF9)‐dependent transcription. In addition, type I IFNs stimulate STAT3 activation in many cell types, an event generally associated with cell cycle progression, survival, and proliferation. To gather more insight into this functionally contradictive phenomenon, we studied the regulation of STAT3 transcriptional activity upon type I IFN treatment. We show that IFNα2 stimulation strongly induces STAT3 phosphorylation, nuclear translocation, and promoter binding, yet the activation of transcription of a STAT3‐dependent reporter and endogenous genes, such as SOCS3 and c‐FOS, is impaired. Simultaneous treatment with IFNα2 and trichostatin A, as well as combined HDAC1/HDAC2 silencing, restores STAT3‐dependent reporter gene and endogenous gene expression, strongly suggesting that HDAC1 and HDAC2 are directly involved in repressing IFNα2‐activated STAT3. Of note, single silencing of only one of the two HDACs does not lead to enhanced STAT3 activity, supporting a functional redundancy between these two enzymes. In sharp contrast, HDAC1 and HDAC2 activities are required for ISGF3‐dependent gene expression. We conclude that HDAC1 and HDAC2 differentially modulate STAT activity in response to IFNα2: while they are required for the induction of ISGF3‐responsive genes, they impair the transcription of STAT3‐dependent genes.—Icardi, L., Lievens, S., Mori, R., Piessevaux, J., De Cauwer, L., De Bosscher, K., Tavernier, J. Opposed regulation of type I IFN‐induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J. 26, 240–249 (2012). www.fasebj.org


Scientific Reports | 2017

TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity

Raffaele Mori; Joris Wauman; Laura Icardi; José Van der Heyden; Lode De Cauwer; Frank Peelman; Karolien De Bosscher; Jan Tavernier

STAT3 is a pleiotropic transcription factor involved in homeostatic and host defense processes in the human body. It is activated by numerous cytokines and growth factors and generates a series of cellular effects. Of the STAT-mediated signal transduction pathways, STAT3 transcriptional control is best understood. Jak kinase dependent activation of STAT3 relies on Y705 phosphorylation triggering a conformational switch that is stabilized by intermolecular interactions between SH2 domains and the pY705 motif. We here show that a second tyrosine phosphorylation within the SH2 domain at position Y640, induced by Tyk2, negatively controls STAT3 activity. The Y640F mutation leads to stabilization of activated STAT3 homodimers, accelerated nuclear translocation and superior transcriptional activity following IL-6 and LIF stimulation. Moreover, it unlocks type I IFN-dependent STAT3 signalling in cells that are normally refractory to STAT3 transcriptional activation.


Cytokine & Growth Factor Reviews | 2017

Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumors

Anna Mondino; Gerlanda Vella; Laura Icardi


Cytokine | 2011

CS16-4. STAT3 transcriptional activity is controlled by regulated acetylation

Jan Tavernier; Laura Icardi; Viola Gesellchen; Raffaele Mori; Sam Lievens; Sven Eyckerman; J. Bultynck; M. Boutros; K. De Bosscher


Cytokine | 2013

125 : The Sin3a repressor complex regulates the balance between the activities of different STAT proteins

Laura Icardi; Raffaele Mori; Viola Gesellchen; Sven Eyckerman; Judith Verhelst; Koen Vercauteren; Xavier Saelens; Philip Meuleman; K. De Bosscher; Michael Boutros; Jan Tavernier


Archive | 2012

The importance of acetylation for STAT signaling

Laura Icardi


Cytokine | 2012

P131 STAT transcriptional activity is controlled by regulated deacetylation

Laura Icardi; Raffaele Mori; Viola Gesellchen; Sven Eyckerman; Judith Verhelst; Koen Vercauteren; Xavier Saelens; Philip Meuleman; K. De Bosscher; Michael Boutros; Jan Tavernier

Collaboration


Dive into the Laura Icardi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Viola Gesellchen

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge